Eisai
4523.T
#2176
Rank
NZ$14.72 B
Marketcap
NZ$52.19
Share price
-0.91%
Change (1 day)
3.24%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Cash on Hand

Cash on Hand as of September 2025 : NZ$3.54 Billion

According to Eisai's latest financial reports the company has NZ$3.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Eisai - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31NZ$3.12 B-7.03%
2024-03-31NZ$3.36 B4.95%
2023-03-31NZ$3.20 B-12.66%
2022-03-31NZ$3.67 B14.07%
2021-03-31NZ$3.21 B-19.47%
2020-03-31NZ$3.99 B3.01%
2019-03-31NZ$3.88 B3.24%
2018-03-31NZ$3.75 B27.74%
2017-03-31NZ$2.94 B16.66%
2016-03-31NZ$2.52 B11.73%
2015-03-31NZ$2.25 B16.14%
2014-03-31NZ$1.94 B-18.1%
2013-03-31NZ$2.37 B-14.2%
2012-03-31NZ$2.76 B-3.44%
2011-03-31NZ$2.86 B24%
2010-03-31NZ$2.31 B-15.02%
2009-03-31NZ$2.71 B79.03%
2008-03-31NZ$1.51 B-28.93%
2007-03-31NZ$2.13 B-21.55%
2006-03-31NZ$2.72 B41.86%
2005-03-31NZ$1.91 B-14.16%
2004-03-31NZ$2.23 B6.8%
2003-03-31NZ$2.09 B-6.42%
2002-03-31NZ$2.23 B-11.05%
2001-03-31NZ$2.51 B-11.93%
2000-03-31NZ$2.85 B